Feature Channels:

Autoimmune Diseases

Add to Favorites Subscribe Share
fbshare-Autoimmune Diseases

Showing results

110 of 814
uci-full-wordmark-blue.png

Article ID: 714000

Nanotechnology treatment shows promise against multiple sclerosis

University of California, Irvine

Irvine, Calif., June 5, 2019 — A nanotechnology treatment derived from bone marrow stem cells has reversed multiple sclerosis symptoms in mice and could eventually be used to help humans, according to a new study led by University of California, Irvine researchers.  “Until now, stem cell therapies for autoimmune and neurodegenerative diseases have produced mixed results in clinical trials, partly because we don’t know how the treatments work,” said corresponding author Weian Zhao, an associate professor of pharmaceutical sciences and biomedical engineering who is affiliated with the Sue & Bill Gross Stem Cell Research Center.

Released:
5-Jun-2019 3:05 PM EDT
Newswise: Newfound autoimmune syndrome causes muscle pain, weakness

Article ID: 713834

Newfound autoimmune syndrome causes muscle pain, weakness

Washington University in St. Louis

A previously unknown autoimmune muscle disease involving sudden onset of debilitating muscle pain and weakness has been identified by researchers at Washington University School of Medicine in St. Louis. The syndrome easily could be mistaken for other muscle diseases that require different treatment, so the findings are expected to help physicians treat patients appropriately, the researchers said.

Released:
3-Jun-2019 11:05 AM EDT
Newswise: Newly Discovered Immune Cell Linked to Type 1 Diabetes

Article ID: 713334

Newly Discovered Immune Cell Linked to Type 1 Diabetes

Johns Hopkins Medicine

Johns Hopkins Medicine researchers say mysterious, previously unseen “X cell” may be cause of type 1 diabetes

Released:
30-May-2019 11:00 AM EDT
Newswise: Deletion in mouse neutrophils offers clues to pathogenesis in multiple sclerosis

Article ID: 713498

Deletion in mouse neutrophils offers clues to pathogenesis in multiple sclerosis

University of Alabama at Birmingham

A mouse model called experimental autoimmune encephalomyelitis, or EAE, is used to discover disease mechanisms in multiple sclerosis. Researchers now report how dysregulated neutrophils cause damage in a severe, mouse model form of EAE called atypical EAE, which attacks cerebellum brain tissue.

Released:
24-May-2019 2:05 PM EDT
mmc-logo.gif

Article ID: 713050

Estudo mostra que droga reduz risco de recaída da neuromielite óptica

Mayo Clinic

O medicamento eculizumab, um anticorpo sintético que inibe a resposta inflamatória, reduziu significativamente o risco de recaída do doenças do espectro neuromielite óptica (NMOSD). Esse distúrbio inflamatório autoimune raro, mas grave, pode causar cegueira, paralisia e morte.

Released:
16-May-2019 3:05 PM EDT
mmc-logo.gif

Article ID: 712885

Pacientes com artrite reumatoide afetados por incapacidades bem antes do diagnóstico

Mayo Clinic

Pacientes diagnosticados com artrite reumatoide são frequentemente afetados por uma incapacidade funcional um a dois anos antes do diagnóstico da doença, de acordo com a nova pesquisa da Mayo Clinic.

Released:
14-May-2019 5:05 PM EDT
mmc-logo.gif

Article ID: 712883

مرضى التهاب المفاصل الروماتويدي يتأثرون بإعاقات قبل التشخيص بفترة طويلة

Mayo Clinic

يتأثر غالبًا المصابون بمرض التهاب المفاصل الروماتويدي بعجز وظيفي قبل تشخيص المرض بسنة أو اثنتين، حسب بحث جديد أجرته Mayo Clinic.

Released:
14-May-2019 5:05 PM EDT
mmc-logo.gif

Article ID: 712638

Estudio muestra que fármaco reduce el riesgo de recaída de neuromielitis óptica

Mayo Clinic

El fármaco eculizumab, un anticuerpo sintético que inhibe la respuesta inflamatoria, redujo considerablemente el riesgo de recaída en el trastorno del espectro de la neuromielitis óptica (NMOSD, por sus siglas en inglés). Este raro y grave trastorno inflamatorio autoinmunitario puede provocar ceguera, parálisis y muerte.

Released:
9-May-2019 11:05 AM EDT
logo_A1_pms124_269-XL.png

Article ID: 712521

UAlbany Biologist Secures $3.4 Million to Study Fibrosis

University at Albany, State University of New York

$3.4 million grant awarded to the University at Albany from the National Institute of Dental and Craniofacial Research will help scientists identify potential therapies for people suffering from the condition.

Released:
8-May-2019 3:05 PM EDT

Showing results

110 of 814

Chat now!